| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/RHEUMATOLOGY/KEW274 |
| P698 | PubMed publication ID | 27477808 |
| P2093 | author name string | Joël Coste | |
| Sébastien Montel | |||
| P2860 | cites work | Is there logic in the placebo? | Q53657127 |
| Commercial features of placebo and therapeutic efficacy. | Q55048934 | ||
| Powerful placebo: the dark side of the randomised controlled trial. | Q55067910 | ||
| The theory of planned behavior | Q56267462 | ||
| Mechanisms of Placebo Pain Reduction: An Empirical Investigation | Q56689460 | ||
| RAMESES publication standards: meta-narrative reviews | Q57270379 | ||
| Placebos without deception: a randomized controlled trial in irritable bowel syndrome | Q21091076 | ||
| Placebo interventions for all clinical conditions | Q24240916 | ||
| Sham device v inert pill: randomised controlled trial of two placebo treatments | Q24537565 | ||
| Neurobiological mechanisms of placebo responses | Q24621444 | ||
| Concept of true and perceived placebo effects | Q24645411 | ||
| Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome | Q24647883 | ||
| Placebo effects: clinical aspects and neurobiology | Q24653735 | ||
| Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration | Q29619618 | ||
| Cortical correlates of false expectations during pain intensity judgments--a possible manifestation of placebo/nocebo cognitions | Q33214979 | ||
| Storylines of research in diffusion of innovation: a meta-narrative approach to systematic review | Q33341163 | ||
| The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials | Q33341591 | ||
| Reproducibility of placebo analgesia: Effect of dispositional optimism | Q33495012 | ||
| Frequency and circumstances of placebo use in clinical practice--a systematic review of empirical studies | Q33533617 | ||
| The placebo effect: illness and interpersonal healing | Q33621740 | ||
| Biological, clinical, and ethical advances of placebo effects | Q33703954 | ||
| An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. | Q33878032 | ||
| Neurobiology of placebo effects: expectations or learning? | Q33878264 | ||
| Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment | Q33948133 | ||
| The powerful placebo | Q33969075 | ||
| Placebo-induced changes in FMRI in the anticipation and experience of pain | Q33976101 | ||
| Do medical devices have enhanced placebo effects? | Q34003166 | ||
| Nocebo-induced hyperalgesia during local anesthetic injection. | Q34020725 | ||
| Deconstructing the placebo effect and finding the meaning response | Q34119138 | ||
| The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? | Q34131341 | ||
| A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia | Q34156800 | ||
| Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo | Q34273139 | ||
| The placebo effect: dissolving the expectancy versus conditioning debate. | Q34300478 | ||
| Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. | Q34377710 | ||
| The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia | Q34394877 | ||
| Endogenous opiates and the placebo effect: a meta-analytic review | Q34410236 | ||
| The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials | Q34411149 | ||
| Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. | Q34445458 | ||
| Goal activation, expectations, and the placebo effect | Q34450838 | ||
| FAAH selectively influences placebo effects | Q34461780 | ||
| Expectations and placebo response: a laboratory investigation into the role of somatic focus | Q34479231 | ||
| Effectiveness and Implications of Alternative Placebo Treatments: A Systematic Review and Network Meta-analysis of Osteoarthritis Trials. | Q34487101 | ||
| Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective | Q34493774 | ||
| Placebo: new insights into an old enigma | Q34623878 | ||
| A comprehensive review of the placebo effect: recent advances and current thought | Q34634630 | ||
| Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses | Q34746177 | ||
| Do "placebo responders" exist? | Q34766089 | ||
| Consistency of the placebo effect | Q34774430 | ||
| Ethical framework for the use of sham procedures in clinical trials | Q35081625 | ||
| How placebo responses are formed: a learning perspective | Q35088475 | ||
| Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures | Q35089406 | ||
| Placebo effect of medication cost in Parkinson disease: a randomized double-blind study | Q35134917 | ||
| Placebo effect studies are susceptible to response bias and to other types of biases | Q35137618 | ||
| The nocebo effect and its relevance for clinical practice | Q35196454 | ||
| Distinct neural representations of placebo and nocebo effects | Q35533444 | ||
| Classical conditioning of analgesic and hyperalgesic pain responses without conscious awareness | Q35796104 | ||
| Placebo effects on human mu-opioid activity during pain | Q35846183 | ||
| A Neural Mechanism for Nonconscious Activation of Conditioned Placebo and Nocebo Responses | Q36098822 | ||
| Psychobiology of the placebo response | Q36413187 | ||
| Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression | Q36593892 | ||
| Personality trait predictors of placebo analgesia and neurobiological correlates | Q36610049 | ||
| A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect | Q37113699 | ||
| New insights into the placebo and nocebo responses | Q37230629 | ||
| "Maybe I made up the whole thing": placebos and patients' experiences in a randomized controlled trial | Q37276983 | ||
| The "placebo" response in osteoarthritis and its implications for clinical practice | Q37467253 | ||
| A systematic review of adverse events in placebo groups of anti-migraine clinical trials | Q37603565 | ||
| Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis | Q37610143 | ||
| Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects | Q37671448 | ||
| Systematic review: Placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy-magnitude and patient-related predictors | Q37856510 | ||
| Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review | Q37984188 | ||
| The placebo response in medicine: minimize, maximize or personalize? | Q38085499 | ||
| The medical alliance: from placebo response to alliance effect | Q38118550 | ||
| Genetics and the placebo effect: the placebome | Q38425277 | ||
| The neuroscience of placebo effects: connecting context, learning and health | Q38531270 | ||
| Investigating the 'placebo personality' outside the pain paradigm | Q38547775 | ||
| The importance of placebo effects in pain treatment and research | Q38571748 | ||
| A meta-analysis of brain mechanisms of placebo analgesia: consistent findings and unanswered questions | Q39115300 | ||
| Problems with the use of placebo conditions in psychotherapy research, suggested alternatives, and some strategies for the pursuit of the placebo phenomenon | Q39217182 | ||
| The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response | Q39305005 | ||
| Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms | Q39366698 | ||
| The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients | Q39390370 | ||
| Variation in the placebo effect in randomised controlled trials of analgesics: all is as blind as it seems | Q39467723 | ||
| Insular cortex activity is associated with effects of negative expectation on nociceptive long-term habituation | Q39844065 | ||
| Harnessing the power of the placebo effect and renaming it "remembered wellness". | Q41036323 | ||
| The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin | Q41499548 | ||
| Placebo and opioid analgesia-- imaging a shared neuronal network | Q42162385 | ||
| The Hawthorne Effect, Sponsored Trials, and the Overestimation of Treatment Effectiveness | Q42675446 | ||
| Response expectancies in placebo analgesia and their clinical relevance | Q43640195 | ||
| Why does choice enhance treatment effectiveness? Using placebo treatments to demonstrate the role of personal control | Q44171524 | ||
| Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors | Q44348000 | ||
| Placebo adverse events in headache trials: headache as an adverse event of placebo | Q44570003 | ||
| The effect of placebo tailoring on smoking cessation: a randomized controlled trial | Q45402868 | ||
| Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study. | Q46922679 | ||
| Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. | Q47229354 | ||
| Daily physical complaints and hippocampal function: an fMRI study of pain modulation by anxiety | Q48429221 | ||
| Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? | Q50148458 | ||
| Placebo analgesia induced by social observational learning. | Q50600120 | ||
| Choice and placebo expectation effects in the context of pain analgesia. | Q50615016 | ||
| Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response. | Q50972827 | ||
| The role of learning in nocebo and placebo effects. | Q51960960 | ||
| Classical conditioning and the placebo effect. | Q52193248 | ||
| Sham procedures and the ethics of clinical trials. | Q53317642 | ||
| P433 | issue | 3 | |
| P921 | main subject | placebo | Q269829 |
| P304 | page(s) | 334-343 | |
| P577 | publication date | 2016-07-31 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Placebo-related effects: a meta-narrative review of conceptualization, mechanisms and their relevance in rheumatology | |
| P478 | volume | 56 |
| Q47555962 | Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain. |
| Q40190115 | Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT). |
| Q41861932 | Possible contribution of quantum-like correlations to the placebo effect: consequences on blind trials |
Search more.